Publication | Open Access

The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myeloma

Hematological MalignancyLymphoid NeoplasiaTransplantationMarrow TransplantationMedicineStem Cell TransplantationImmunologyHematologyMultiple Myeloma30-Day ReadmissionOncologyCell Transplantation